EHA Unplugged

In this episode, Dr Michael Milsom discusses how thehematopoietic system aging is a complex process with multiple causes. Dr Milsom proposes a more holistic view of the driving mechanisms of hematopoietic andimmune aging that does not focus solely on HSCs. He describes how inflammation‑driven stem cell activation and proliferation cause functional attrition and clonalselection of HSCs, contributing to clonal hematopoiesis. Learn about the mechanisms of blood cells aging andpotential interventions to slow down the process. Guest: Dr Michael Milsom Head of the Division of Experimental Hematology at the German Cancer Research Center, (DKFZ), and group leader at the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI‑STEM), Heidelberg, Germany Host: Isabel Olivera Martinez, PhD Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. ⁠Provide Feedback⁠ Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. ⁠https://ehaedu.org/Campus⁠ Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: ⁠https://www.instagram.com/EHA_Hematology/⁠ Facebook: ⁠https://e-h-a.link/facebook⁠ LinkedIn: ⁠https://www.linkedin.com/company/eha/⁠ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via ⁠https://eha.news/subscribe⁠

Get up to date with the latest EHA-EU guideline for Mantle Cell Lymphoma (EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma - Jerkeman - 2025 - HemaSphere - Wiley Online Library) with Prof Mats Jerkeman (Lund University, Sweden). In this episode, he explains how biological risk factors, particularly TP53 mutations and proliferation rate, inform patient stratification. He reviews evolving treatment sequencing, including the expanding role of BTK inhibitors (such as ibrutinib) in first-line regimens. He further discusses the management relapsed/refractory MCL, where BTK inhibitors and CAR T-cell therapy have largely supplanted but not fully replaced allogeneic transplantation. Throughout the conversation, Prof Jerkeman emphasizes the dynamic evolution of MCL treatment and the need for ongoing guideline updates as new evidence emerges. Link to the guideline: (EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma - Jerkeman - 2025 - HemaSphere - Wiley Online Library) Link to Lund University: Mats Jerkeman - Lund University Home | Lund University Learn More Interested in more content related to CART? We've got you covered. Check out free CART program on ⁠EHA Campus⁠. What did you think of this podcast? Share your opinions with us in this short feedback survey. ⁠Provide Feedback⁠ Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. ⁠https://ehaedu.org/Campus⁠ Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: ⁠https://www.instagram.com/EHA_Hematology/⁠ Facebook: ⁠https://e-h-a.link/facebook⁠ LinkedIn: ⁠https://www.linkedin.com/company/eha/⁠ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via ⁠https://eha.news/subscribe⁠

[This is a Rerelease. Episode first published on July 19, 2024.]Join us for a conversation with Jonathan Clark, a patient advocate who has been in remission for over five years after receiving CAR T-cell therapy for Mantle Cell Lymphoma. Jonathan shares his journey from relapse to recovery, detailing the challenges and triumphs of this cutting-edge treatment from a patient’s perspective. With host Dr. Sarah de Vlieger, they discuss his motivation for sharing his story and the profound physical and psychological impacts of long-term remission. Jonathan also talks about managing long-term side effects like immunodeficiencies and how apparently small changes can significantly improve quality of life. He emphasizes the importance of understanding the patient's perspective, advocating for quality of life improvements, and the need for personalized care that goes beyond medical statistics. Jonathan highlights the global disparities in accessing advanced treatments like CAR T-cell therapy and concludes with a call to prioritize quality of life in treatment decisions. Host: Dr Sarah de Vlieger Guest: Jonathan Clark This episode is part of a series recorded at the joint EHA-EBMT 6th European CAR T-cell meeting in Valencia in February 2024. Learn More Interested in more content related to CART? We've got you covered. Check out free CART program on ⁠EHA Campus⁠. What did you think of this podcast? Share your opinions with us in this short feedback survey. ⁠Provide Feedback⁠ Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. ⁠https://ehaedu.org/Campus⁠ Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: ⁠https://www.instagram.com/EHA_Hematology/⁠ Facebook: ⁠https://e-h-a.link/facebook⁠ LinkedIn: ⁠https://www.linkedin.com/company/eha/⁠ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via ⁠https://eha.news/subscribe⁠

[This is a Rerelease. Episode first published on November 22, 2024.]Join us in this podcast episode to get a glimpse of what the future holds in the big field of innovation in hematology. With the help of our host, Dr Gregor Hormann (MLL Munich Leukemia Laboratory, Germany), you will be taken on a journey toward a future that is already here. Dr Hormann will discuss the many potentials of AI in hematology and oncology, including the automated integrated diagnostic tools, from morphology to chromosomal banding analysis in a few minutes, new classification algorithms, and innovative large language models (LLMs) assisting physicians in the diagnosis prediction. The take-home message? "AI will not replace physicians. However, physicians who use AI will replace those who don't." Host: Dr Wilson Lim Guest: Dr Gregor Hormann Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. ⁠Provide Feedback⁠ Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. ⁠https://ehaedu.org/Campus⁠ Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: ⁠https://www.instagram.com/EHA_Hematology/⁠ Facebook: ⁠https://e-h-a.link/facebook⁠ LinkedIn: ⁠https://www.linkedin.com/company/eha/⁠ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via ⁠https://eha.news/subscribe⁠

[This is a Rerelease. Episode first published on November 1, 2024.] Join us for an engaging episode with Dr. Stephen Hibbs from Queen Mary University of London as he discusses the environmental impacts of hematology. Alongside our host Dr. Sarah de Vlieger, they explore how climate change is already affecting hematology, emphasizing that these effects are being felt now rather than in the future. The conversation highlights how climate change alters aspects of hematology practice, such as the risk of transfusion-transmitted infections due to evolving disease vectors. Dr. Hibbs describes also the surprising link between extreme heat during pregnancy and an increased risk of children developing ALL (acute lymphoblastic leukemia). He further discusses practice-changing initiatives, like using sevoflurane instead of desflurane as an anesthetic to reduce environmental impact, and explains his work on improving the logistics of blood transfusions to lessen their ecological footprint. Finally, Dr. Hibbs encourages hematologists to focus on actionable steps to minimize their environmental impact, advocating for practical changes in clinical practices and increased awareness of the healthcare sector's contribution to global emissions. Host: Dr Sarah de Vlieger Guest: Dr Stephen Hibbs Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. ⁠Provide Feedback⁠ Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. ⁠https://ehaedu.org/Campus⁠ Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: ⁠https://www.instagram.com/EHA_Hematology/⁠ Facebook: ⁠https://e-h-a.link/facebook⁠ LinkedIn: ⁠https://www.linkedin.com/company/eha/⁠ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via ⁠https://eha.news/subscribe⁠

[This is a Rerelease. Episode first published on April 11, 2025.] Listen to Dr. Jan Moritz Middeke from University Hospital in Dresden as he discusses the future of clinical trials in hematology and the role artificial intelligence (AI) may play in that field. Dr. Middeke explains how synthetic data is generated and what are the potential benefits and limitations of its use in clinical trials. He also points out the open questions and hurdles that need to be addressed before AI-generated synthetic patients can be included in clinical trial design. Tune in to hear how Dr. Middeke envisages the role of AI in solving the challenges of clinical trials for rare malignant diseases and how it may accelerate data generation and access to novel therapies. If you want to know more: ⁠https://www.nature.com/articles/s41746-024-01076-x⁠ Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Dr. Jan Moritz Middeke Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. ⁠https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1⁠ Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. ⁠https://ehaedu.org/Campus⁠ Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: ⁠https://www.instagram.com/EHA_Hematology/⁠ Facebook: ⁠https://e-h-a.link/facebook⁠ LinkedIn: ⁠https://www.linkedin.com/company/eha/⁠ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via ⁠https://eha.news/subscribe⁠

Join us for this interview with Dr Río-Machín from Autonomous University of Madrid in Spain as she discusses her research on rare subtypes of acute myeloid leukemia (AML), which she conducted thanks to the EHA Junior Research Grant. Her discovery of transcriptional activator of key leukemia drivers in one of these subtypes may pave way to new therapeutic approaches. Tune in to hear dr. Río-Machín‘s call for more collaborative research to achieve impactful results for patients in the future. Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Dr Ana Río-Machín Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this discussion between Prof Argiris Symeonidis from University of Patras in Greece and Prof Sam Salek from University of Hertfordshire in UK who focus on the role of the hematologist in the diagnosis and management of patients with Gaucher disease. Prof Symeonidis and Prof Salek are both experts in recognizing and treating this rare lysosomal storage disorder and share their recommendations for hematologists to ensure earlier detection of this disease. Host: Prof. Sam Salek, University of Hertfordshire, UK Guest: Prof. Argiris Symeonidis, University of Patras, Rion, Greece Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this inspiring interview with Erik Aerts from University Hospital Zurich in Switzerland and Mairéad Ní Chonghaile from St. James’s Hospital in Ireland who discuss their extensive work within the Hematology Nurses & Healthcare Professionals Group (HNHCP). Erik, the President, and Mairéad, the Vice-President of HNHCP, describe their unwavering commitment to providing hematology education to nurses and other healthcare professionals to ensure the best possible care for their patients. Tune in to hear what their thoughts are on the future of nursing in hematology and how they envisage addressing its biggest challenges. Host: Isabel Olivera-Martinez, PhD, Medical Writer Guests: Erik Aerts, Nurse Manager, University Hospital Zurich, Switzerland and President of Hematology Nurses & Healthcare Professionals Group (HNHCP) Mairéad Ní Chonghaile, Bone Marrow Transplant Coordinator, St. James’s Hospital, Dublin, Ireland and Vice-President of HNHCP Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this inspiring interview with prof. Jesús San-Miguel from Clínica Universidad de Navarra in Spain who discusses his extensive work to improve care for patients with multiple myeloma. Prof San-Miguel’s research and clinical contributions have shaped the current treatment landscape for multiple myeloma. For his contributions, he has received the 2025 EHA Lifetime Achievement Award. Tune in to hear his thoughts about the future of multiple myeloma management and the crucial role that collaborative research will play in it. Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Prof Jesús San-Miguel, Clínica Universidad de Navarra, Spain Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this interview with Dr Mandy Lauw from Erasmus Medical Center in Rotterdam, Netherlands who describes her work to increase the visibility and voice of young hematologists within the EHA. For her unwavering efforts to improve the support and opportunities for young hematologists at the beginning of their career, Dr Lauw has been awarded the Young EHA Award. Tune in to hear about the many educational and mentoring programs EHA has available for young hematologists. Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Dr Mandy Lauw Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this interview with Dr Ferran Nadeu Prat from August Pi i Sunyer Biomedical Research Institute in Barcelona, Spain who discusses his work on evolution of chronic lymphocytic leukemia (CLL), which he conducted thanks to the EHA Junior Research Grant. Dr Nadeu Prat explains how the new insights into CLL evolution toward Richter transformation, which is a lethal complication of CLL, may lead to new therapeutic approaches. Tune in to hear his views on the future of this field and the role of collaborative research in achieving these goals. Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Dr Ferran Nadeu Prat, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this conversation with prof. Mariane de Montalembert from Necker-Enfants Malades Hospital in France who discusses the current standards of care for patients with sickle cell disease and thalassemia, both in Europe and in sub-Saharan Africa. Prof. de Montalembert highlights the inequalities and the unique challenges in implementation of complex innovative treatments, such as gene therapy. Tune in to hear her thoughts on the possible solutions for these challenges and future directions in this field. Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Prof Mariane de Montalembert, Necker-Enfants Malades Hospital, Paris, France Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this inspiring interview with prof Béatrice Gulbis from The Brussels University Hospital in Belgium who discusses her extensive work on implementing neonatal screening for sickle cell disease (SCD) in low-resource countries in Africa. Prof Gulbis has been involved in collaborative projects to implement the testing methods that best fit the specific contexts. Tune in to hear her recommendations for the optimal SCD screening systems and her hopes for the worldwide collaborative approach to improve care for patients with SCD. Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Prof Béatrice Gulbis, The Brussels University Hospital, Belgium Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this interview with dr. Côme Bommier from Saint-Louis Hospital in Paris, France who describes the results of the recent EHA survey on burnout symptoms among hematology professionals in Europe. Dr. Bommier discusses the findings of the survey in the context of modifiable systemic factors. Tune in to hear him urge organizational reforms to ensure better work environments for hematologists, leading ultimately to better outcomes for patients. Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Dr. Côme Bommier, Saint-Louis Hospital, Paris, France Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this inspiring conversation with prof. Anna Schuh from University of Oxford in the United Kingdom who describes her efforts to improve access to care for patients with hematological diseases in East African countries. Prof. Schuh describes the experience of sharing her time between the UK and East Africa and how this has impacted her clinical practice in both environments. Tune in to hear what her views are on how the Global North and Global South can learn from each other to improve care for patients everywhere. Host: Wilson Lim, PhD, Medical Writer Guest: Prof Anna Schuh, University of Oxford, United Kingdom Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this inspirational interview with prof. Jan Cools from KU Leuven in Belgium who received the EHA 2025 Education & Mentoring Award. Prof. Cools describes his approach to mentoring students and scientists, emphasizing the aspects that he finds most crucial in this role. Tune in to hear his thoughts about the future of mentoring, the place artificial intelligence may take in it and the importance of failure on the road to success. Host: Isabel Olivera-Martinez, PhD, Medical Writer, EHA Guest: Prof. Jan Cools, KU Leuven Department of Human Genetics, Belgium Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

In this episode, we sit down with prof. Khaled Musallam from Burjeel Medical City in United Arab Emirates who discusses his extensive work to improve care for patients with thalassemia. Prof. Musallam’s research and clinical contributions have reshaped the management of both non-transfusion-dependent thalassemia (NTDT) and transfusion-dependent thalassemia (TDT). Tune in to hear his views on the current practice and future directions in the prevention and treatment of morbidities associated with thalassemia. For a comprehensive review of all aspects of thalassemia, the EHA Thalassemia Program is available to all EHA Members on Campus. Stay tuned for future episodes! Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Prof Khaled Musallam Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this discussion between Robin Doeswijk, EHA European Affairs and prof. John Gribben from Barts Cancer Institute in the United Kingdom on the topic of equity in care of patients with hematologic malignancies. This discussion follows the recently published “European Cancer Organisation Essential Requirements for Quality Cancer Care: Hematological Malignancies”. Tune in to hear how this combination of organizational guidelines and clinical practice recommendations aims to improve diagnosis and care for all patients across Europe. Host: Robin Doeswijk, EHA European Affairs Guest: Prof John Gribben Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe

Join us for this captivating interview with Prof Kirsten Grønbæk from University of Copenhagen in Denmark, as she discusses her outstanding career in the field of hematology, both in research and in the clinics. Listen to how the interests of Prof Grønbæk evolved, leading her from the initial focus on epigenetics in lymphomas to MDS in the later years of her career. Prof Grønbæk reflects on the current developments in MDS and her tips for the leading a successful research team in hematology. Host: Isabel Olivera-Martinez, PhD, Medical Writer Guest: Prof Kirsten Grønbæk Learn More What did you think of this podcast? Share your opinions with us in this short feedback survey. https://forms.monday.com/forms/d02e52896815eef59ecae09fb74dd78f?r=use1 Would you like to explore more eLearning or podcasts? Please visit the EHA Campus. https://ehaedu.org/Campus Subscribe, share, and review this podcast to be able to address topics you enjoy and like to listen to. Follow EHA on Instagram: https://www.instagram.com/EHA_Hematology/ Facebook: https://e-h-a.link/facebook LinkedIn: https://www.linkedin.com/company/eha/ Email us: education@ehaweb.org Subscribe to receive the EHA Educational Updates via https://eha.news/subscribe